Denali Therapeutics
DNLI
#4008
Rank
โ‚น257.28 B
Marketcap
โ‚น1,754
Share price
-0.81%
Change (1 day)
-16.99%
Change (1 year)

Denali Therapeutics (DNLI) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น94.82 Billion

According to Denali Therapeutics 's latest financial reports the company's total assets are โ‚น94.82 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Denali Therapeutics - Total assets on balance sheet (from 2016 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น117.88 B22.72%
2023-12-31โ‚น96.06 B-20.5%
2022-12-31โ‚น120.83 B15.62%
2021-12-31โ‚น104.51 B-10.92%
2020-12-31โ‚น117.32 B197.4%
2019-12-31โ‚น39.45 B-14.77%
2018-12-31โ‚น46.28 B48.94%
2017-12-31โ‚น31.07 B68.71%
2016-12-31โ‚น18.42 B655.62%
2015-12-31โ‚น2.43 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novocure
NVCR
โ‚น122.26 B 28.95% Jersey
Novavax
NVAX
โ‚น105.98 B 11.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
โ‚น1.31 B-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น18.16 B-80.84%๐Ÿ‡ฌ๐Ÿ‡ง UK